TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity
Year: 2025
Type: article
Abstract: Not available.
Source: Haematologica
Authors: Shih-Syuan Cheng, Jing-Gu Jiang, Shih-Chiang Lin, Yueh-Hsiang Yu, Tse Wen Chang, Carmay Lim, Yuan-Bin Yu, Hsing-Mao Chu
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
Funder: Far Eastern Memorial Hospital
OpenAlex ID: W4415952029
FWCI:
Cites:
Cited by:
Related to:
